Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment

World Journal of Biological Psychiatry

Volumn 11, Issue 6, 2010, Pages 774-780

  Forlenza, Orestes Vicente ^a   Diniz, Breno Satler ^a   Teixeira, Antonio Lucio ^b   Ojopi, Elida Benquique ^a   Talib, Leda Leme ^a   Mendonça, Vanessa Amaral ^b   Izzo, Giselle ^a   Gattaz, Wagner Farid ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Alzheimer's disease; APOE; Brain derived neurotrophic factor polymorphisms; Mild cognitive impairment; Neurotrophic cascade

Indexed keywords

APOLIPOPROTEIN E; BRAIN DERIVED NEUROTROPHIC FACTOR;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE INTERACTION; HUMAN; MALE; MILD COGNITIVE IMPAIRMENT; PROTEIN BLOOD LEVEL;

AGED; ANALYSIS OF VARIANCE; APOLIPOPROTEINS E; BRAIN-DERIVED NEUROTROPHIC FACTOR; COGNITION DISORDERS; COHORT STUDIES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX;

EID: 77955635771     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622971003797241     Document Type: Article

References (30)

1. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. J Mol Biol 215:403-410.
2. Chételat G, Landeau B, Eustache F, Mézenge F, Viader F, de La Sayette V, et al. 2005. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study. Neuroimage 27:934-946.
3. (2A) levels. Exp Neurol 210:164-171.
4. Cunha AB, Frey BN, Andreazza AC, Goi JD, Rosa AR, Gonçalves CA, et al. 2006. Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci Lett 398:215-219.
5. Davatzikos C, Xu F, Yang A, Fan Y, Resnick SM. 2009. Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index. Brain 132:2026-2035.
6. de Oliveira GS, Ceresér KM, Fernandes BS, Kauer-Sant'Anna M, Fries GR, Stertz L, et al. 2009 Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients. J Psychiatr Res 43:1171-1174.
7. Diniz BS, Nunes PV, Yassuda MS, Pereira FS, Flaks MK, Viola LF, et al. 2008a. Mild cognitive impairment: cognitive screening or neuropsychological assessment? Rev. Bras. Psiquiatr 30:316-321.
8. Diniz BS, Pinto Junior JA, Forlenza OV. 2008b. Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature. World J Biol Psychiatry 9:172-182.
9. Diniz BS, Teixeira AL, Talib LL, Mendon ç a VA, Gattaz WF, Forlenza OV. 2010. Serum brain-derived neurotrophic factor level is reduced in antidepressant-free patients with late-life depression. World J Biol Psychiatry 11:550-555.
10. Folstein MF, Folstein SE, Mchugh PR. 1975. Mini-Mental State: A Practical Method for Grading the Cognitive State of Patients for the Clinician. J Psychiatr Res 12:189-198.
11. Forlenza OV, Diniz BS, Nunes PV, Memória CM, Yassuda MS, Gattaz WF. 2009. Diagnostic transitions in mild cognitive impairment subtypes. Int Psychogeriatr 21:1088-1095.
12. Hashimoto R, Hirata Y, Asada T, Yamashita F, Nemoto K, Mori T, et al. 2009. Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease. Genes Brain Behav 8:43-52.
13. Holsinger RM, Schnarr J, Henry P, Castelo VT, Fahnestock M. 2000. Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease. Brain Res Mol Brain Res 76:347-354.
14. Kunugi H, Ueki A, Otsuka M, Isse K, Hirasawa H, Kato N, et al. 2001. A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease. Mol Psychiatry 6:83-86.
15. Leyhe T, Stransky E, Eschweiler GW, Buchkremer G, Laske C, 2008. Increase of BDNF serum concentration during donepe-zil treatment of patients with early Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 258:124-128.
16. Li G, Peskind ER, Millard SP, Chi P, Sokal I, et al. 2009. Cerebro-spinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects. PLoS one 4(5):e5424.
17. Livak KJ. 1999. Allelic discrimination using fluorogenic probes and the 59 nuclease assay. Genet Anal 14:143-149.
18. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. 1984. Clinical Diagnosis of Alzheimer Disease: Report of NINCDS-ADRDA Work Group under the Auspices of Department of Health and Human Service Task Force on Alzheimer Disease. Neurology 34:939-944.
19. Nagahara AH, Merrill DA, Coppola G, Tsukada S, Schroeder BE, Shaked GM, et al. 2009. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer ' s disease. Nat Med 15:331-337.
20. Nakahashi T, Fujimura H, Altar CA, Li J, Kambayashi J, Tandon NN, Sun B. 2000. Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett 470:113-117.
21. Nemoto K, Ohnishi T, Mori T, Moriguchi Y, Hashimoto R, Asada T, Kunugi H. 2006. The Val66Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology. Neurosci Lett 397:25-29. (Pubitemid 43340452)
22. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ. 1998. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37:1553-1561.
23. Peng S, Wuu J, Mufson EJ, Fahnestock M. 2005. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer' s disease. J Neurochem 93:1412-1421.
24. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. 2001. Current concepts in mild cognitive impairment. Arch Neurol 58:1985-1992.
25. Reis HJ, Nicolato R, Barbosa IG, Teixeira PH, Romano-Silva MA, Teixeira AL. 2008. Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia. Neurosci Lett 439:157-159.
26. Roth M, Tym E, Mountjoy CQ, Huppert FA, Hendrie H, Verma S, Goddard R. 1986. CAMDEX: a standardized instrument for the diagnosis of mental disorders in the elderly with special reference to early detection of dementia. Br J Psychiatry 149:698-709.
27. Scalzo P, Kümmer A, Bretas TL, Cardoso F, Teixeira AL. 2010. Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson's disease. J Neurol 257:540-545.
28. Tapia-Arancibia L, Aliaga E, Silhol M, Arancibia S. 2008. New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Res Rev 59:201-220.
29. Yasutake C, Kuroda K, Yanagawa T, Okamura T, Yoneda H. 2006. Serum BDNF, TNF-alpha and IL-1beta levels in dementia patients: comparison between Alzheimer's disease and vascular dementia. Eur Arch Psychiatry Clin Neurosci 256:402-406.
30. Yu H, Zhang Z, Shi Y, Bai F, Xie C, Qian Y, Yuan Y, Deng L. 2008. Association study of the decreased serum BDNF concentrations in amnestic mild cognitive impairment and the Val66Met polymorphism in Chinese Han. J Clin Psychiatry 69:1104-1111.